These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 2935251)

  • 1. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 5. Future clinical investigations with anthracycline antibiotics in relation to daunorubicin.
    Muggia FM; Blum RH; Wernz JC
    Cancer Treat Rep; 1981; 65 Suppl 4():35-7. PubMed ID: 6955012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline analogs: the past, present, and future.
    Weiss RB; Sarosy G; Clagett-Carr K; Russo M; Leyland-Jones B
    Cancer Chemother Pharmacol; 1986; 18(3):185-97. PubMed ID: 2948729
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current status of clinical results of new antitumor drugs].
    Ogawa M
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):179-88. PubMed ID: 3918502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anthracycline antitumor antibiotics.
    Muggia FM; Green MD
    Crit Rev Oncol Hematol; 1991; 11(1):43-64. PubMed ID: 1831987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New anthracyclines].
    Ogawa M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):27-33. PubMed ID: 8422185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture.
    Arcamone F
    Cancer Res; 1985 Dec; 45(12 Pt 1):5995-9. PubMed ID: 3864526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
    Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
    Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
    [No Abstract]   [Full Text] [Related]  

  • 12. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
    Ganapathi R; Grabowski D; Schmidt H; Seshadri R; Israel M
    Biochem Biophys Res Commun; 1985 Sep; 131(2):912-9. PubMed ID: 2932108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.
    Hurteloup P; Ganzina F
    Drugs Exp Clin Res; 1986; 12(1-3):233-46. PubMed ID: 3525075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.
    Bhuyan BK; McGovren JP; Crampton SL
    Cancer Res; 1981 Mar; 41(3):882-7. PubMed ID: 6450639
    [No Abstract]   [Full Text] [Related]  

  • 15. [New anthracyclines in the treatment of solid tumors in the advanced stage].
    Pannuti F; Martoni A; Lelli G; Camaggi CM; Strocchi E; Fruet F
    G Ital Chemioter; 1985; 32(1):49-56. PubMed ID: 3868636
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
    Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
    Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1981; 76():21-40. PubMed ID: 6940212
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxic and mutagenic in vitro effect of 7-O-epoxyalkyl derivatives of daunomycinone. Part IX.
    Sturdíková M; Fusková A; Prikrylová V; Podojil M; Fuska J
    Neoplasma; 1986; 33(3):297-305. PubMed ID: 2426609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
    Chandrasekaran B; Dimling J; Capizzi RL
    Cancer Treat Rep; 1987 Feb; 71(2):195-6. PubMed ID: 2948640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.